Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Royalty Pharma plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MSCI Inc. April 21, 202695.4%
-
Royalty Pharma plc May 12, 202599.1%
-
MSCI Inc. April 22, 202594.0%
-
Royalty Pharma plc June 6, 202496.2%
-
MSCI Inc. April 23, 202495.1%
-
Royalty Pharma plc June 22, 202385.3%
-
MSCI Inc. April 25, 202396.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2026 | MSCI Inc. | Open-market purchase | +120 | $559.40 | $67,128 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +240 | $560.28 | $134,467 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +1,238 | $561.56 | $695,211 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +1,122 | $562.47 | $631,091 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +800 | $563.39 | $450,712 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +400 | $564.42 | $225,768 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +80 | $565.17 | $45,214 |
| Apr 28, 2026 | MSCI Inc. | Gift | −75,707 | — | — |
| Apr 28, 2026 | MSCI Inc. | Gift | +75,707 | — | — |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +240 | $517.32 | $124,157 |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +360 | $519.45 | $187,002 |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +200 | $520.00 | $104,000 |
| Feb 13, 2026 | MSCI Inc. | Open-market purchase | +6,000 | $524.18 | $3,145,080 |
| Dec 5, 2025 | MSCI Inc. | Open-market purchase | +360 | $531.98 | $191,513 |
| Dec 5, 2025 | MSCI Inc. | Open-market purchase | +1,124 | $533.12 | $599,227 |
Questions about Henry A. Fernandez
What boards is Henry A. Fernandez on?
Henry A. Fernandez sits on the boards of MSCI Inc. and Royalty Pharma plc.
What company is Henry A. Fernandez the CEO of?
Henry A. Fernandez is Chairman and CEO of MSCI Inc.
How long has Henry A. Fernandez served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.